Tenderwize
Back to tender search

Open House Contract for Peginterferon beta 1a

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2028 · 712 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 20 - Peginterferon beta 1a

56/100

Opportunity Score

Needs reviewHigh complexity
SuppliesOpen
Why this score?

Opportunity

56 / 100

Complexity

68 / 100

Risk factors

Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...

Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Conclude non-exclusive discount agreements for Peginterferon beta 1a under § 130a Abs. 8 SGB V.
  • Provide pharmaceutical products for nationwide performance in Germany.
Show full summary

This is a German Open House supply arrangement by Techniker Krankenkasse for the active substance Peginterferon beta 1a (CPV 33600000 Pharmaceutical products). It is not an exclusive award procedure: all pharmaceutical undertakings meeting the stated conditions may enter into the contract on uniform terms. The contract term is up to 24 months from 01.08.2026 and ends no later than 31.07.2028, with earlier automatic termination if patent/market exclusivity ends. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. No contract value is stated.

Risks

Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...

Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4 Abs. 18 AMG for the offered medicine(s).
  • Applicant must have its registered seat in the scope of the AMG, another EU Member State, or another EEA state.
  • Applicant must have a valid authorisation for the contract medicine or otherwise be entitled to market it in its own name.

Award Criteria

Lot 1

No substantive award criteria stated; form-only criterion in an Open House procedure.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Contract for Peginterferon beta 1a

Open House supply arrangement for Peginterferon beta 1a. The notice indicates nationwide performance in Germany. Contract terms are uniform and non-exclusive; no individual negotiations are conducted. The lot information is taken from structured data and XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jul 2026 - Jul 2028

Category

Pharmaceutical products

Award Criteria

No substantive award criteria stated; form-only criterion in an Open House procedure.

Deadline

Deadline Jul 30, 2028

Procurement Details

Publication date
31 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
372206-2026

Documents (1)

Similar tenders